ChartMill assigns a Buy % Consensus number of 71% to CNST. The Buy consensus is the weighted average rating of the current analysts ratings.
7 analysts have analysed CNST and the average price target is 41.53 null. This implies a price increase of 22.18% is expected in the next year compared to the current price of 33.99.
The consensus rating for Constellation Pharmaceuticals Inc (CNST) is 71.4 / 100 . This indicates that analysts generally have a positive outlook on the stock.